β-Amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK-3β, and PTEN

Neurochemistry International

Volumn 50, Issue 1, 2007, Pages 229-235

  Nassif, Melissa ^a   Hoppe, Juliana ^a   Santin, Katiane ^a   Frozza, Rudimar ^a   Zamin, Lauren L ^a   Simão, Fabrício ^a   Horn, Ana P ^a   Salbego, Christianne ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Amyloid; Akt; Alzheimer's disease; GSK 3 ; Organotypic culture; PTEN

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[25-35]; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROPIDIUM IODIDE; PROTEIN KINASE B;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DRUG EXPOSURE; HIPPOCAMPUS; IMMUNOBLOTTING; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

AMYLOID BETA-PROTEIN; ANIMALS; BLOTTING, WESTERN; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; MALE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RATS;

EID: 33845321718     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.08.008     Document Type: Article

References (52)

1. Abdel-Hamid K.M., and Tymianski M. Mechanisms and effects of intracellular calcium buffering on neuronal survival in organotypic hippocampal cultures exposed to anoxia/aglicemia or to excitotoxins. J. Neurosci. 17 (1997) 3538-3553
2. Abe K., Hisatomi R., and Misawa M. Amyloid β-peptide specifically promotes phosphorylation and nuclear translocation of the extracellular signal-regulated kinase in cultured rat cortical astrocytes. J. Pharmacol. Sci. 93 (2003) 272-278
3. Baskys A., and Adamchik Y. Neuroprotective effects of extracellular glutamate are absent in hippocampal organotypic cultures treated with the amyloid peptide Aβ(25-35). Brain Res. 13 (2001) 188-194
4. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., and Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Fork head transcription factor. Cell 19 (1999) 857-868
5. Caricasole A., Copani A., Caruso A., Caraci F., Iacovelli L., Sortino M.A., Terstappen G.C., and Nicoletti F. The Wnt pathway, cell-cycle activation and β-amyloid: novel therapeutic strategies in Alzheimer's disease?. Trends Pharmacol. Sci. 24 (2003) 233-238
6. Casal C., Serratosa J., and Tusell J.M. Effects of β-AP peptides on activation of the transcription factor NF-kappaB and in cell proliferation in glial cell cultures. Neurosci. Res. 48 (2004) 315-323
7. Chan T.O., Rittenhouse S.E., and Tsichlis P.N. Akt/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 68 (1999) 965-1014
8. Chow L.M., and Baker S.J. PTEN function in normal and neoplastic growth. Cancer Lett. 241 2 (2006) 184-196
9. Cimarosti H., Zamin L.L., Frozza R., Nassif M., Horn A.P., Tavares A., Netto C.A., and Salbego C. Estradiol protects against oxygen and glucose deprivation in rat hippocampal organotypic cultures and activates Akt and inactivates GSK-3β. Neurochem. Res. 30 (2005) 191-199
10. Cook D., Fry M.J., Hughes K., Sumathipala R., Woodgett J.R., and Dale T.C. Wingless inactivates glycogen synthase kinase-3 via an intracellular signaling pathway which involves a protein kinase C. EMBO J. 15 (1996) 4526-4536
11. Dall'Igna O.P., Porciuncula L.O., Souza D.O., Cunha R.A., and Lara D.R. Neuroprotection by caffeine and adenosine A2A receptor blockade of β-amyloid neurotoxicity. Br. J. Pharmacol. 138 (2003) 1207-1209
12. Dineley K.T., Westerman M., Bui D., Bell K., Ashe K.H., and Sweatt J.D. β-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 21 (2001) 4125-4133
13. Downward J. How BAD phosphorylation is good for survival. Nat. Cell Biol. 1 (1999) E33-E35
14. D'Ursi A.M., Armenante M.R., Guerrini R., Salvadori S., Sorrentino G., and Picone D. Solution structure of amyloid β-peptide (25-35) in different media. J. Med. Chem. 12 (2004) 4231-4238
15. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., and Loike J.D. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382 (1996) 716-719
16. Forman M.S., Trojanowski J.Q., and Lee V.M. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. 10 (2004) 1055-1063
17. Fuentealba R.A., Farias G., Scheu J., Bronfman M., Marzolo M.P., and Inestrosa N.C. Signal transduction during amyloid-β-peptide neurotoxicity: role in Alzheimer disease. Brain Res. Rev. 47 (2004) 275-289
18. Giunta S., Galeazzi R., Valli M.B., Corder E.H., and Galeazzi L. Transferrin neutralization of amyloid β-25-35 cytotoxicity. Clin. Chim. Acta. 350 (2004) 129-136
19. Guan Z.Z., Miao H., Tian J.Y., Unger C., Nordberg A., and Zhang X. Suppressed expression of nicotinic acetylcholine receptors by nano molar beta-amyloid peptides in PC12 cells. J. Neural. Transm. 108 (2001) 1417-1433
20. Haas C. The molecular significance of amyloid beta-peptide for Alzheimer's disease. Eur. Arch. Psy. Clin. Neurosci. 246 (1996) 118-123
21. Holopainen I.E. Organotypic hippocampal slice cultures: a model system to study basic cellular and molecular mechanisms of neuronal cell death, neuroprotection, and synaptic plasticity. Neurochem. Res. 30 (2005) 1521-1528
22. Horn A.P., Gerhardt D., Geyer A.B., Valentim L., Cimarosti H., Tavares A., Horn F., Lenz G., and Salbego C. Cellular death in hippocampus in response to PI3-K pathway inhibition and oxygen and glucose deprivation. Neurochem. Res. 30 (2005) 355-361
23. Hüll M., Muksch B., Akundi R.S., Waschbisch A., Hoozemans J.J., Veerhuis R., and Fiebich B.L. Amyloid beta peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes. Neurochem. Int. 48 8 (2006) 663-672
24. Inestrosa N.C., De Ferrari G.V., Garrido J., Alvarez A., Olivares G.H., Barria M.I., Bronfman M., and Chacón M.A. Wnt signaling involvement in β-amyloid-dependent neurodegeneration. Neurochem. Int. 41 (2002) 341-344
25. Ito Y., Ito M., Takagi N., Saito H., and Ishige K. Neurotoxicity induced by amyloid beta-peptide and ibotenic acid in organotypic hippocampal cultures: protection by S-allyl-l-cysteine, a garlic compound. Brain Res. 985 (2003) 98-107
26. Kim D., and Chung J. Akt: versatile mediator of cell survival and beyond. J. Biochem. Mol. Biol. 35 (2001) 106-115
27. Kosuge Y., Sakikubo T., Ishige K., and Ito Y. Comparative study of endoplasmic reticulum stress-induced neuronal death in rat cultured hippocampal and cerebellar granule neurons. Neurochem. Int. 49 3 (2006) 285-293
28. Kowall N.W., McKee A.C., Yankner B.A., and Beal M.F. In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment. Neurobiol. Aging. 13 5 (1992) 537-542
29. Leslie N.R., and Downes C.P. PTEN: the down side of PI 3-kinase signaling. Cell. Signal 14 (2002) 285-295
30. Lu X.H., Bradley R.J., and Dwyer D.S. Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38. Brain Res. 1011 (2004) 58-68
31. Macklis J.D., and Madison R.D. Progressive incorporation of propidium iodide in cultured mouse neurons correlates with declining electrophysiological status: a fluorescence scale of membrane integrity. J. Neurosci. Method 31 (1990) 43-46
32. Martín D., Salinas M., López-Valdaliso R., Serrano E., Recuero M., and Cuadrado A. Effect of the Alzheimer amyloid fragment Aβ(25-35) on Akt/PKB kinase and survival of PC12 cells. J. Neurochem. 78 (2001) 1000-1008
33. Mateo I., Infante J., Llorca J., Rodriguez E., Berciano J., and Combarros O. Association between glycogen synthase kinase-3β genetic polymorphism and late-onset Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 21 (2006) 228-232
34. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
35. Misiti F., Sampaolese B., Pezzotti M., Marini S., Coletta M., Ceccarelli L., Giardina B., and Clementi M.E. A beta(31-35) peptide induce apoptosis in PC 12 cells: contrast with a beta(25-35) peptide and examination of underlying mechanisms. Neurochem. Int. 46 7 (2005) 575-583
36. Nicotra A., Lupo G., Giurdanella G., Anfuso C.D., Ragusa N., Tirolo C., Marchetti B., and Alberghina M. MAPKs mediate the activation of cytosolic phospholipase A2 by amyloid (25-35) peptide in bovine retina pericytes. Biochim. Biophys. Acta 1733 (2005) 172-186
37. Noraberg J., Kristensen B.W., and Zimmer J. Markers for neuronal degeneration in organotypic slice cultures. Brain Res. Protoc. 3 (1999) 278-290
38. Noraberg J., Poulsen F.R., Blaabjerg M., Kristensen B.W., Bonde C., Montero M., Meyer M., Gramsbergen J.B., and Zimmer J. Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 435-452
39. Pap M., and Cooper G.M. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 273 (1998) 19929-19932
40. Qi X.L., Xiu J., Shan K.R., Xiao Y., Gu R., Liu R.Y., and Guan Z.Z. Oxidative stress induced by beta-amyloid peptide (1-42) is involved in the altered composition of cellular membrane lipids and the decreased expression of nicotinic receptors in human SH-SY5Y neuroblastoma cells. Neurochem. Int. 46 8 (2005) 613-621
41. Ryder J., Su Y., and Ni B. Akt/GSK3β serine/threonine kinases: evidence for a signaling pathway mediated by familial Alzheimer's disease mutations. Cell Signal 16 (2004) 187-200
42. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399 (1999) A23-A31
43. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid β-protein. Ann. NY Acad. Sci. 924 (2000) 17-25
44. Stoppini L., Buchs P.A., and Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Method 37 (1991) 173-182
45. Tavares A., Cimarosti H., Valentim L., and Salbego C. Profile of phosphoprotein labelling in organotypic slice cultures of rat hippocampus. Neuroreport 12 (2001) 2705-2709
46. Ugi S., Imamura T., Maegawa H., Egawa K., Yoshizaki T., Shi K., Obata T., Ebina Y., Kashiwagi A., and Olefsky J.M. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol. Cell. Biol. 24 (2004) 8778-8789
47. Valentim L.M., Rodnight R., Geyer A.B., Horn A.P., Tavares A., Cimarosti H., Netto C.A., and Salbego C.G. Changes in heat shock protein 27 phosphorylation and immunocontent in response to preconditioning to oxygen and glucose deprivation in organotypic hippocampal cultures. Neuroscience 118 (2003) 379-386
48. Wei W., Wang X., and Kusiak J.W. Signaling events in amyloid β-peptide-induced neuronal death and insulin-like growth factor I protection. J. Biol. Chem. 277 (2002) 17649-17656
49. Yankner B.A., Duffy L.K., and Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β-protein: reversal by tachykinin neuropeptides. Science 250 (1990) 279-282
50. Yan S.D., Chen X., Fu J., Chen M., Zhu H.J., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A.M. RAGE and amyloid-b peptide neurotoxicity in Alzheimer's disease. Nature 382 (1996) 685-691
51. Yuan J., and Yankner A. Apoptosis in the nervous system. Nature 407 (2000) 802-809
52. Zamin L.L., Dillenburg-Pilla P., Argenta-Comiran R., Horn A.P., Simao F., Nassif M., Gerhardt D., Frozza R.L., and Salbego C. Protective effect of resveratrol against oxygen-glucose deprivation in organotypic hippocampal slice cultures: involvement of PI3-K pathway. Neurobiol Dis. 24 (2006) 170-182